Could, what bothers me is that we have been told over the years waiting for a BO, wait for R-I results, wait for approval, wait for trial results, yada, yada. Meanwhile I see companies being bought out before even having reached phase III trials.
Whether it is JT with expectations that are too lofty or what I am not sure.
If we can believe what he says, there has been some interest in Europe but he admits he wants a higher valuation.